Alterola Biotech
(OTC) ABTI
Alterola Biotech Financials at a Glance
Market Cap
$7.44M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.20M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
33.16 (High)
Dividend
$0.00
Beta (Volatility)
33.16 (High)
Price
$0.01
Volume
10,000
Open
$0.01
Price
$0.01
Volume
10,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.20
Dividend
$0.00
Beta (Volatility)
33.16 (High)
Price
$0.01
Volume
10,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.20
ABTI News
ABTI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alterola Biotech
Industry
Pharmaceuticals
Sector
Health CareEmployees
1
CEO
David John Hitchcock
Website
alterola-abti.comHeadquarters
Birkenhead, CH41 5AR, GB
ABTI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-19%
Return on Assets
-12%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.44M
Shares Outstanding
1.46B
Volume
10.00K
Short Interest
0.00%
Avg. Volume
3.01K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.90M
EBITDA
$1.70M
Operating Cash Flow
$1.04M
Capital Expenditure
$139.80K
Free Cash Flow
$1.18M
Cash & ST Invst.
$8.89K
Total Debt
$1.41M
Alterola Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.44M
N/A
Market Cap/Employee
$7.44M
N/A
Employees
1
N/A
Net Income
$123.16K
+67.2%
EBITDA
$123.16K
+73.8%
Quarterly Fundamentals
Net Cash
$1.54M
-211.9%
Accounts Receivable
$9.10K
-125.4%
Inventory
$975.00
+9.2%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$1.55M
+317.2%
Return on Assets
-12.46%
N/A
Return on Invested Capital
-18.51%
N/A
Free Cash Flow
$122.16K
+38.1%
Operating Cash Flow
$122.16K
+38.1%